Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1963 of 6351
-
Custom-Made vaccine takes on untreated leukemia in early trial
Disease control Recruiting nowThis research study is studying a novel type of CLL vaccine as a possible treatment for chronic lymphocytic leukemia (CLL) The names of the study interventions involved in this study are: * Personalized NeoAntigen Vaccine * Poly-ICLC * Cyclophosphamide * Pembrolizumab
Phase 1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Can blood markers predict brain injury outcomes?
Knowledge-focused CompletedAcute brain injury due to traumatic brain injury (TBI), intracerebral haemorrhage (ICH), and aneurysmal subarachnoid haemorrhage (SAH) carries a high morbidity and mortality, in part due to the development of secondary brain injury. The mechanisms behind secondary brain injury ar…
Sponsor: Rigshospitalet, Denmark • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Could skin cells heal stubborn leg wounds? new trial tests a One-Time treatment
Disease control CompletedThe aim of this clinical trial is to investigate the efficacy (by monitoring the wound size reduction of CVUs) and safety (by monitoring adverse events \[AEs\]) of three dose groups of the investigational medicinal product (IMP) allo-APZ2-CVU, topically administered on target wou…
Phase 2 • Sponsor: RHEACELL GmbH & Co. KG • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Rapid HIV tests could end the epidemic by diagnosing in minutes
Diagnosis CompletedThis study proposes to investigate the performance of existing and new technologies for HIV diagnosis, one of the key strategies for Ending the HIV Epidemic in the U.S. Current, Standard-of-Care (SOC) diagnostic techniques have extended turn-around-times (TATs) that result in los…
Sponsor: Johns Hopkins University • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
Promising combo tackles rare lung cancer in small trial
Disease control CompletedEvaluate the efficacy and safety of tislelizumab in combination with anlotinib in patients with stage III and IV PSC .
Phase 2 • Sponsor: Second Affiliated Hospital of Nanchang University • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Front vs back surgery: which is better for stiff spine condition?
Disease control OngoingThe purpose of this study is to compare the efficacy, safety and imaging outcomes between Anterior Controllable Antedisplacement and Fusion (ACAF) and Laminoplasty in the treatment of severe ossification of cervical posterior longitudinal ligament.
Sponsor: Shanghai Changzheng Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New drug combo shows promise for Tough-to-Treat liver cancer
Disease control CompletedThis phase II trial studies the effect of futibatinib and pembrolizumab in treating patients with FGF19 positive BCLC stage A, B, or C liver cancer that has spread to other parts of the body (advanced or metastatic). Futibatinib may stop the growth of cancer cells by blocking som…
Phase 2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Frozen hope: new study offers fertility option for rare condition
Disease control Recruiting nowThe "Gonadal Dysgenesis Tissue Cryopreservation for Fertility Preservation" study is open to a subset of patients with disorders of sex development (DSD) which is associated with the risk of malignancy and a high risk of infertility or sterility. For these patients, experimental …
Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 26, 2026 18:05 UTC
-
Could stem cells mend broken hearts in diabetes?
Disease control CompletedThe purpose of this study is to test the hypothesis that allogeneic Mesenchymal Stem Cells (MSCs) promote systemic and coronary endothelial repair through rescue of bone marrow progenitors in type 2 diabetic patients with symptomatic IHD compared to placebo.
Phase 1/2 • Sponsor: Joshua M Hare • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New powder dressing shows promise for healing diabetic foot sores
Disease control CompletedPhase IV, randomized, prospective, multi-center, open-label, comparison of transforming powder dressing to standard of care dressing for healing diabetic foot ulcers.
Sponsor: ULURU Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New drug safety check for Hard-to-Treat lymphoma patients
Disease control OngoingThe primary purpose of the study is to investigate the safety of tazemetostat in participants with relapsed or refractory follicular lymphoma with EZH2 gene mutation under daily clinical practice.
Sponsor: Eisai Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Sound waves zapping pain: new hope for facial neuralgia?
Symptom relief OngoingThe purpose of this study is to assess the safety and effectiveness of MRI-guided focused ultrasound (MRgFUS) for treating Trigeminal Neuralgia. Trigeminal Neuralgia (pain) is a type of pain involving the face that can be disabling to those it affects.
Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC
-
Blood test could spare cancer patients from unnecessary side effects
Knowledge-focused Recruiting nowThe FOLICOLOR trial aims to evaluate whether a liquid biopsy-guided follow-up strategy can improve outcomes in patients with unresectable, metastatic colorectal cancer (mCRC) receiving first-line systemic treatment. The approach uses NPY methylation-based circulating tumor DNA (c…
Phase 3 • Sponsor: University Hospital, Antwerp • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC
-
Ancient herb mix put to the test against stubborn hives
Disease control CompletedUrticaria is a common skin disorder and 15-25% of people experience at least one attack of urticaria during their lifetime. Urticaria can be divided into acute urticaria (AU) and chronic urticaria (CU). CU is more common in adults, and affects women more frequently than men. Acco…
Phase 2 • Sponsor: Prof. Lin Zhixiu • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
New study aims to find best way to unblock stomachs in cancer patients
Symptom relief By invitation onlyGastric outlet obstruction (GOO) refers to a mechanical blockage of the distal stomach or duodenum that prevents normal passage of food and liquids. According to literature, 50-80% of GOO cases are caused by malignant tumors compressing or directly invading the gastrointestinal t…
Sponsor: National Taiwan University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
Experimental drug combo targets Hard-to-Treat GI cancers
Disease control OngoingThis phase I trial investigates the best dose, possible benefits and/or side effects of BAY 1895344 in combination with FOLFIRI in treating patients with stomach or intestinal cancer that that may have spread from where it first started to nearby tissue, lymph nodes, or distant p…
Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
New study explores letrozole's effects on breast cancer before surgery
Disease control OngoingThis is a single-arm, open-label study testing the effects of neoadjuvant therapy with the aromatase inhibitor letrozole in post-menopausal women with Stage I-III ER+, HER2- breast cancer. Eligible subjects will be treated with letrozole therapy for 4 to 24 weeks prior to surgica…
Phase 2 • Sponsor: Dartmouth-Hitchcock Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
A smartphone app takes on heavy drinking and STIs in high-risk men
Disease control CompletedThe proposed study involves conducting a larger-scale study exploring Game Plan's effects among MSM in the real-world, alongside innovative approaches for expanding HIV testing. Using a hybrid 1 effectiveness-implementation approach, the investigators will recruit up to 360 high-…
Sponsor: Brown University • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC
-
Smart radiation aims to zap liver tumors with fewer side effects
Disease control Recruiting nowStereotactic body radiotherapy (SBRT) is an established local treatment method for patients with hepatic oligometastases. Liver metastases often occur in close proximity to radiosensitive organs at risk (OARs). This limits the possibility to apply sufficiently high doses needed f…
Phase 2 • Sponsor: University Hospital Heidelberg • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New hope for asthma and polyp sufferers? mepolizumab under the microscope
Disease control CompletedPrimary objective: to investigate the efficacy of Mepolizumab 100 milligram (mg) every month compared to placebo in reducing validated Sinonasal Outcome Test -22 score and on reducing endoscopic Nasal Polyp Score. The participants have a triad of chronic rhinosinusitis with nasa…
Phase 4 • Sponsor: Helsinki University Central Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC